Renovorx Inc (RNXT)

Dec 11, 2025

RenovoRx (Nasdaq: RNXT) to Present TIGeR-PaC PK/PD Data at ASCO GI Symposium 2026 - Stock Titan

Dec 11, 2025

Dec 09, 2025

Transcript : RenovoRx, Inc. Presents at IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025, Dec-09-2025 through Dec-10-2025 - marketscreener.com

Dec 09, 2025

Dec 09, 2025

RNXT: Six-month survival benefit and strong early revenue position the company for growth in 2026 - TradingView

Dec 09, 2025

Dec 08, 2025

Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025 - Investing News Network

Dec 08, 2025

Dec 08, 2025

Agah Ramtin, RenovoRx chief medical officer, buys $9,600 in RNXT - Investing.com

Dec 08, 2025

Dec 05, 2025

Is RenovoRx Inc. stock near bottom after declineJuly 2025 Chart Watch & Precise Entry and Exit Recommendations - Newser

Dec 05, 2025

Dec 03, 2025

What makes RenovoRx Inc. stock attractive to growth funds2025 Momentum Check & Weekly Chart Analysis and Guides - Newser

Dec 03, 2025

Dec 01, 2025

RenovoRx (RNXT) Stock Analysis Report | Financials & Insights - Benzinga

Dec 01, 2025

Dec 01, 2025

RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9th - Investing News Network

Dec 01, 2025

Dec 01, 2025

RenovoRx CEO to Present at iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 - Quiver Quantitative

Dec 01, 2025

Dec 01, 2025

RenovoRx (Nasdaq: RNXT) CEO to detail RenovoCath updates at iAccess Alpha - Stock Titan

Dec 01, 2025

Nov 26, 2025

RenovoRx files $50M mixed securities shelf - MSN

Nov 26, 2025

Nov 26, 2025

Big Money Moves: Is RenovoRx Inc. stock attractive for growth ETFsMarket Trend Review & Safe Entry Zone Tips - BỘ NỘI VỤ

Nov 26, 2025

Nov 24, 2025

RenovoRx CMO Makes Bold Stock Purchase - TipRanks

Nov 24, 2025

Nov 24, 2025

[Form 4] RenovoRx, Inc. Insider Trading Activity - Stock Titan

Nov 24, 2025

Nov 24, 2025

RenovoRx CMO Ramtin Agah Acquires 22,000 Shares - TradingView

Nov 24, 2025

Nov 23, 2025

Cipla Limited (CIPLA) Gets Regulatory ApprovalFinancial Sector Performance & Stay One Step Ahead of Risk Events - earlytimes.in

Nov 23, 2025

Nov 21, 2025

Is RenovoRx Inc. stock positioned for long term growthRisk Management & Reliable Volume Spike Trade Alerts - newser.com

Nov 21, 2025

Nov 21, 2025

Is RenovoRx Inc. stock a top pick in earnings seasonWeekly Profit Report & Community Driven Trade Alerts - newser.com

Nov 21, 2025

Nov 20, 2025

RenovoRx Expands Reach with RenovoCath Approval - MSN

Nov 20, 2025

Nov 19, 2025

Is RenovoRx Inc. stock dividend yield sustainablePortfolio Growth Summary & Risk Managed Investment Signals - newser.com

Nov 19, 2025

Nov 19, 2025

Published on: 2025-11-19 17:29:20 - newser.com

Nov 19, 2025

Nov 19, 2025

Tick level data insight on RenovoRx Inc. volatility2025 Retail Activity & Safe Investment Capital Preservation Plans - newser.com

Nov 19, 2025

Nov 19, 2025

How to integrate RenovoRx Inc. into portfolio analysis toolsQuarterly Trade Summary & Weekly High Return Stock Opportunities - newser.com

Nov 19, 2025

Nov 19, 2025

RenovoRx CEO Shaun Bagai to Present at the Alliance Global Partners Emerging AgBiotech/Bio-Solutions Virtual Showcase on November 20th - Investing News Network

Nov 19, 2025

Nov 19, 2025

RenovoRx CEO Shaun Bagai to Present at Alliance Global Partners Virtual Showcase on Oncology Innovations - Quiver Quantitative

Nov 19, 2025

Nov 19, 2025

RenovoRx (Nasdaq: RNXT) to Share RenovoCath, $900K YTD Revenue at AGP Showcase - Stock Titan

Nov 19, 2025

Nov 19, 2025

What drives RenovoRx Inc stock pricePrice Gap Trading Strategies & Go Beyond the Headlines With Analyst Picks - earlytimes.in

Nov 19, 2025

Nov 19, 2025

Does RenovoRx Inc. fit your quant trading modelJuly 2025 Breakouts & Verified Chart Pattern Signals - newser.com

Nov 19, 2025

Nov 18, 2025

RenovoRx : Corporate Overview - MarketScreener

Nov 18, 2025

Nov 18, 2025

Strategic Expansion and Promising Clinical Results Justify Buy Rating for RenovoRx - TipRanks

Nov 18, 2025

Nov 17, 2025

Can RenovoRx Inc. stock deliver consistent earnings growthJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - newser.com

Nov 17, 2025

Nov 15, 2025

RenovoRx launches public stock offering - MSN

Nov 15, 2025

Nov 15, 2025

Is RenovoRx Inc. stock supported by innovation pipelineBull Run & Free Safe Entry Trade Signal Reports - newser.com

Nov 15, 2025

Nov 15, 2025

Can machine learning forecast RenovoRx Inc. recoveryJuly 2025 Opening Moves & Intraday High Probability Alerts - newser.com

Nov 15, 2025

Nov 15, 2025

RenovoRx Earnings Call: Positive Momentum and Strategic Growth - MSN

Nov 15, 2025

Nov 15, 2025

RenovoRx’s Innovative Cancer Treatment and Promising Phase 3 Study Drive Buy Rating - TipRanks

Nov 15, 2025

Nov 15, 2025

RenovoRx price target lowered to $3 from $3.50 at Alliance Global - MSN

Nov 15, 2025

Nov 15, 2025

Analysts Offer Insights on Healthcare Companies: RenovoRx (RNXT) and Forte Biosciences (FBRX) - The Globe and Mail

Nov 15, 2025

Nov 15, 2025

What analyst consensus says on RenovoRx Inc. stockWeekly Investment Recap & Smart Swing Trading Alerts - newser.com

Nov 15, 2025